Coloplast
{{Short description|Danish medical devices manufacturer}}
{{Infobox company
| name = Coloplast A/S
| logo = Coloplast.svg
| logo_size = 255px
| type = Publicly traded Aktieselskab
| traded_as = {{OMX|CSE3203|COLO B}}
| founder = Aage Louis-Hansen
| key_people = Kristian Villumsen (President and CEO), Lars Rasmussen (Chairman) Niels Peter Louis-Hansen (Deputy chairman)
| industry = Health care
| products = Ostomy bags, continence products, urology products, wound dressings
| revenue = DKK 18.544 billion (2019/2020){{cite web|url=https://investor.coloplast.com/globalassets/content-blocks/multisite-pages/ir/reports/annual-reports/annual-report-2019-20.pdf|access-date=31 August 2021|publisher=Coloplast|title=Annual Report 2019/20}}
| operating_income = DKK 5.854 billion (2020/2021, before special items)
| assets = DKK 13.499 billion (September 2021)
| equity = DKK 5.928 billion (September 2021)
| num_employees = 12,500 (FTE, September 2021)
| foundation = {{start date and age|1957}}
| location_city = Humlebæk
| location_country = Denmark
| homepage = [http://www.coloplast.com/ www.coloplast.com]
}}
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care.
History
Coloplast was founded in 1957 by Aage Louis-Hansen. His son Niels Peter Louis-Hansen owns 20% of the company and is deputy chairman.{{cite web|title=Niels Peter Louis-Hansen|url=https://www.forbes.com/profile/niels-peter-louis-hansen/|access-date=18 January 2015|website=Forbes}} It employs more than 12,000 people and operates around the world, with sales activities in 53 countries and production in Denmark, Hungary, France, China and the US.{{Cite web|title=Investor Relations - Corporate|url=http://www.coloplast.com/ECompany/CorpMed/Homepage.nsf/(VIEWDOCSBYID)/870090EA69DFA2A3C12573980041F1CF?OpenDocument&Ref=&unid=6005ECBEF0394260C12573980041D26E|website=Coloplast}} It has its global headquarters in Humlebæk, Denmark. Its United States operations and North American headquarters are based in Minneapolis, Minnesota. The company manufactures and supplies products to hospitals and institutions, as well as wholesalers and retailers. In selected markets, Coloplast is a direct supplier to consumers.
The company had revenues of DKK 18.554 billion in 2020/2021. Europe constitutes the biggest market with 63% of sales, while 22% of sales are in North America and 15% in the rest of the world. Coloplast is listed on the Danish Stock Exchange, and has for a number of years been represented among the 20 most traded shares in the country.{{cite web|title=Gynækolog Niels Lund Middelfart|url=https://www.linkedin.com/in/niels-lund-gyn%C3%A6kolog-middelfart-fyn-6a0900127/|access-date=5 February 2017|website=LinkedIn}}
In 2016, Coloplast was listed as the 22nd most innovative company in the world by Forbes.{{Cite web|date=30 August 2016|title=10 Most Innovative Companies In Europe 2016: Coloplast|url=https://www.forbes.com/pictures/hjfe45fl/coloplast/?sh=2f7084db20ed|website=Forbes}} In 2015, Coloplast was listed as the 33rd most innovative company in the world by Forbes Magazine. The company has been featured in The Star Tribune's annual list of top employers in Minnesota.{{cite web|date=2018|title=The World's Most Innovative Companies|url=https://www.forbes.com/innovative-companies/list/|access-date=14 December 2015|website=Forbes}}
In November 2021, Coloplast announced the acquisition for 2.5 billion dollars of Atos Medical, specialized in laryngectomy, which belonged to PAI Partners.{{Cite news|date=2021-11-08|title=Coloplast to acquire Atos Medical in $2.5 billion deal, shares rise|language=en|work=Reuters|url=https://www.reuters.com/article/atos-medical-m-a-coloplast-idUSKBN2HT0MX|access-date=2022-08-25}}
Acquisitions
In 2010, the company acquired Mpathy Medical Devices.{{Cite web|last=Lee|first=Thomas|date=2010-10-29|title=Coloplast buys Mpathy Medical for $30M leg up in incontinence|url=https://medcitynews.com/2010/10/coloplast-buys-mpathy-medical-for-30-million/|access-date=2021-07-27|website=MedCity News|language=en-US}}
In November 2016, Coloplast acquired Comfort Medical for $160 million. Comfort Medical was a direct-to-consumer medical supplier based in Coral Springs, Florida. Prior to the acquisition from Coloplast, Comfort Medical had acquired Medical Direct Club as well as Liberty Medical's urological business area in 2015. In 2020, Coloplast announced the acquisitions of Hope Medical and Rocky Medical Supply, and integrated the organizations into Comfort Medical.{{Cite web|date=16 June 2017|title=Coloplast to buy Comfort Medical for $160M|url=https://www.paragonventures.com/market-pulse-posts/coloplast-to-buy-comfort-medical-for-160m/|access-date=2021-07-27|website=Paragon Ventures|language=en-US}}{{Cite news|author=|date=2016-12-01|title=BRIEF-Coloplast acquires Comfort Medical in US|language=en|work=Reuters|url=https://www.reuters.com/article/idUSASM0007OF|access-date=2021-07-27}}
In November 2021, Coloplast announced it would acquire Atos Medical and its laryngectomy technology for 2.16 billion euros ($2.49 billion).{{Cite news|date=8 November 2021|title=Coloplast to acquire Atos Medical in $2.5 billion deal, shares rise|newspaper=Reuters|url=https://www.reuters.com/article/atos-medical-m-a-coloplast/coloplast-to-acquire-atos-medical-in-2-5-billion-deal-shares-rise-idUSKBN2HT0MX}}
Transvaginal surgical mesh lawsuits
In 2019, the U.S. Food and Drug Administration ordered Coloplast and Boston Scientific to halt the sale and distribution of transvaginal surgical mesh implants for failure to prove their mesh products were safe and effective for the repair of pelvic organ prolapse.{{cite web|url=https://www.fiercebiotech.com/medtech/fda-orders-boston-scientific-and-coloplast-to-halt-transvaginal-mesh-sales|title=FDA orders Boston Scientific, Coloplast to halt transvaginal mesh sales|last=Hale|first=Conor|date=19 April 2019|website=Fierce Biotech|access-date=30 August 2021}} Coloplast was one of several companies that had previously settled multimillion-dollar lawsuits for damages caused by transvaginal mesh implants.{{cite web|url=https://www.drugwatch.com/transvaginal-mesh/verdict-settlement/|title=Transvaginal Mesh Verdicts and Settlements|last=Llamas|first=Michelle|date=June 2019|website=Drugwatch|access-date=30 August 2021}}
References
{{Reflist}}
External links
- {{Official website|http://www.coloplast.com}}
{{OMX Copenhagen 20 companies}}
{{OMX Nordic 40}}
{{Authority control}}
Category:Companies listed on Nasdaq Copenhagen
Category:Companies in the OMX Copenhagen 25
Category:Companies in the OMX Nordic 40
Category:Companies in the S&P Europe 350 Dividend Aristocrats
Category:Health care companies of Denmark
Category:Companies based in Fredensborg Municipality